To examine the prevalence of nightmares in people with psychosis and to describe the link between nightmares and sleep quality, psychotic, affective, and cognitive symptoms.
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Clinical Implications
• Reports of nightmares should form part of a routine assessment for people with psychotic symptoms presenting with disturbed sleep.
• People experiencing more distressing nightmares tend to present with more severe daytime symptomatology.
• Nightmare-related distress may prove to be a novel target for psychological therapies for people experiencing symptoms of psychosis.
Limitations
• A convenience sample was recruited and as such may not be representative of all people experiencing symptoms of psychosis.
• Our study collected cross-sectional data, and causal statements about associations cannot be discerned.
• Our study was powered to detect medium-to-large correlations, increasing the risk of type II error for some analyses.
T he past 5 years have drawn attention to major sleep disruption in people with psychosis. [1] [2] [3] [4] Poor sleep is a risk factor for developing first-episode psychosis 5 and is predictive of the onset and maintenance of paranoid ideas, 6 a poorer-quality of life, 7,8 and frontal-executive task performance difficulties. 4 Attempts to characterize the sleep patterns of people with psychosis have revealed various disturbances. 2, 9 These include increased time spent in bed, higher sleep latency, disrupted melatonin sulphate levels, circadian rhythm disruption, and lastly, more fragmented sleep. 2, 9 It is likely that numerous different sleep disorders account for this variety of sleep profiles, and that each requires a different treatment focus. For example, there is already evidence of increased rates of both insomnia 3 and obstructive sleep apnea 10 in samples with psychosis. A sleep disorder that has received little attention in this group is nightmare disorder.
Nightmares
Nightmares are typically characterized by awakening from rapid-eye movement sleep with recollection of disturbing mental activity. 11 Large epidemiologic studies estimate that weekly nightmares occur in 0.9% to 6.8% of the general population. [11] [12] [13] Nevertheless, for people with diagnoses such as PTSD 14, 15 and BPD, 16 this estimated prevalence rate increases to 49% to 71%. Nightmares have been associated with increased psychological distress, 16, 17 worse physical health outcomes, 18 and increased risk for self-harm and suicide. 16, 19 Whereas previously nightmares have been viewed as a symptom of other disorders, they are now regarded as a specific, comorbid, and treatable condition. 18, 20, 21 It has been proposed that nightmares and psychotic symptoms represent a common domain with shared etiology. 22 There is preliminary evidence that this may be the case. Frequent nightmares in early childhood increased the risk of later psychotic experiences in adolescents. 23 Nightmare-related distress predicted levels of paranoia and psychoticism in a sample of healthy students, 24 and increased frequency of nightmares have been observed in people with SSD diagnoses. 22, 25 
Study Aims
Our study aimed to investigate the phenomenology of nightmares in the context of psychosis. Four key hypotheses were tested: 1) Nightmares will be more prevalent in the context of psychosis than in the general population.
2) Nightmare frequency will be associated with poorer sleep (PSQI sleep quality and sleep efficiency).
3) Nightmare-related distress, rather than the frequency with which they occur, will best account for the association between nightmares and daytime impairment (psychotic symptoms, affective symptoms, and daytime activities) while controlling for shared variance.
4)
Poorer sleep quality will be associated with poorer working memory. More specifically, it is expected that a higher frequency of nightmares will be associated with poorer working memory (a cognitive deficit commonly observed in people experiencing psychosis 26, 27 ).
Method
Participants
Forty participants were recruited from in-and outpatient services in 2 south London NHS foundation trusts. Inclusion criteria were for the participant to be aged 18 or older; to have experienced symptoms of psychosis; to have proficient use of the English language for the purpose of completing questionnaires; and to be able to provide informed consent. Exclusion criteria included a primary diagnosis of alcohol or substance dependency, an organic syndrome, such as a dementia, or having a learning disability. Participants were aware that the study was investigating "sleep patterns," but the information sheet stated the following: "whether you sleep very well, or have had sleep difficulties we would like to hear from you."
Measures
Sociodemographic, diagnosis, prescribed medication, and alcohol and drug use data were collected. Where participants were unsure of their diagnosis, prescribed medication name and (or) dose was taken from medical notes.
The PSQI 28 measured sleep quality during the month prior to assessment. The sleep efficiency (number of hours asleep divided by number of hours in bed) and overall sleep quality scales were used for analysis. The 7 PSQI component scores have good internal consistency (Cronbach α = 0.83) and yield acceptable test-retest reliability. 28 The measure has previously been used in samples with psychosis. 29 A retrospective dream log was adapted from Levin and Fireman. 24 Participants were asked to indicate how many nightmares they estimated experiencing during the past 2 weeks (14 nights). If the participant had experienced at least 1 nightmare, they were asked to pick their worst nightmare and rate it on a 7-point Likert scale for intensity, vividness, and distress, and also to mark whether it was recurrent (yes or no). Retrospective nightmare logs measuring up to 1 month in the past are known to yield similar results to prospective measures in a sample of undergraduate students. 29
The Psychotic Symptoms Rating Scale
The PSYRATS 30 measured the severity of 11 dimensions of auditory hallucinations and 6 dimensions of delusions via 5-point scales (0 to 4). Evaluation of the PSYRATS delusions and hallucinations scales indicate good interrater reliability 30 and concurrent validity with the Positive and Negative Syndromes Scale. 31
The Depression, Anxiety and Stress Scales
The DASS-21 32 provide 3 scales of these negative emotional states, derived from 21 self-report items. The scales reflect experiences during the preceding week. The 3 scales have demonstrated very good internal consistency (all Cronbach α > 0.90) and good test-retest reliability for a sample with schizophrenia. 33
The Posttraumatic Diagnostic Scale
The PDS 34 was administered as a self-report measure of PTSD symptomatology. The measure of symptom severity was used for analysis. It has been shown to have high internal consistency, test-retest reliability, and high diagnostic validity when compared with the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Axis I disorders 35 and good sensitivity and specificity. 34 The questionnaire has been used in a previous study recruiting people with psychotic symptoms. 36
The Time Budget Questionnaire The Time Budget Questionnaire 37 was administered to assess use of time during the preceding week. The measure was designed specifically for people with symptoms of psychosis. Activities were rated according to complexity of activity and effort required. The measure has been shown to have convergent validity regarding activity levels and social contact. 37
The Digit Span Subtest The Digit Span subtest from the Wechsler Memory Scale, Third Edition, 38 was administered to assess working memory and offered a standardized (scaled) score for each participant.
The Digit Span has a reliability coefficient of 0.86.
Procedure
The study was approved by City Road and Hampstead NHS Research Ethics Committee (11/LO/2045). Informed consent was obtained, following which each participant completed the full assessment, with breaks as required.
Participants provided demographic, medication, and alcohol and drug use data. Following this, participants completed the PSYRATS for hallucinations and delusions with the researcher. The PSQI, dream log, 24 and DASS-21 were completed independently but with the option of using the researcher as a scribe. Following this, the PDS, the Time Budget Questionnaire, and the Digit Span subtest were completed with the researcher. The order of assessment measures was held constant across participants. Diagnosis was confirmed by medical records from the treating psychiatrist; clinicians in the United Kingdom use the World Health Organization's International Classification of Diseases system.
Analysis
PASW Statistics for Windows, version 18.0, 39 was used to perform all inferential statistics, with the exception of 95% confidence interval for proportions, which was calculated using an online calculator by Graphpad.com. 40 Because the distribution of nightmare frequency and distress data was skewed, nonparametric correlation coefficients (2-tailed Spearman rho) were used to assess hypotheses 2 and 4. Partial Spearman correlation coefficients (2-tailed) were carried out by performing partial Pearson productmoment correlation coefficient with ranked data. 41 Hochberg's improved Bonferroni procedure was used to adjust for multiple comparisons.
Results
Demographics and Clinical Characteristics of the Sample
Letters were sent to 108 people on a research register held by a specialist psychosis clinic (PICuP, SLaM). Among the 108 invitation letters sent, 28 participants were recruited. Among 21 other patients referred by their care team, 12 participants were recruited.
The first 40 participants who consented took part in the study. Twenty-five (62.5%) were male, with age ranging from 18 to 68 years (mean 41.9); 57.5% were white (British, Irish or Other), the remainder were from black and minority ethnic groups (20% Black African, 5% Black Caribbean, 2.5% Asian, and 15% Other). Four participants were inpatients, 36 were outpatients. Inpatients experienced a mean of 0 nightmares during the past 2 weeks (SD 0), while outpatients experienced 6.51 (SD 13.12). The sleep quality of inpatients revealed a mean PSQI score of 5.00 (SD 0.50), while for outpatients it was 10.00 (SD 4.08).
Clinical characteristics are outlined in Table 1 . All participants experienced auditory hallucinations or delusions. Length of time experiencing positive symptoms of psychosis ranged from 3 months to 41 years. There was 1 person who had a missing value for 1 question on the PSYRATS for delusions, across all 40 participants. This score was calculated from the mean of the scores from the other 5 items for that participant.
Thirty-six of the 40 (90%) participants had a current SSD diagnosis or bipolar affective disorder with psychotic symptoms; the remaining 4 participants all had active symptoms of psychosis and were recruited from a specialist psychosis clinic (PICuP, SLaM).
Seventeen (42.5%) participants screened positive for PTSD. Eleven of these 17 participants (65%) reported weekly nightmares. This was not significantly higher than the 10 of 20 (50%) participants who reported weekly nightmares but did not screen positive for PTSD (n = 37; χ 2 = 0.81, df = 1, P > 0.05). The median nightmare distress score for participants who screened positive for PTSD was 5.00, which was not significantly different from the median (6.00) of those who screened negative for PTSD (U = 88.50, z = -0.13, P = 0.90). Nine of the 40 participants had taken nonprescribed drugs or medications in the week prior to assessment date. Among these 9, 2 reported taking cannabis (5% of total sample). The remaining 7 took over-the-counter medications (for example, Kalms Tablets, paracetamol, and multivitamins). Median weekly alcohol intake was 0 units (range 0 to 80 units). The recommended daily intake of alcohol in the United Kingdom is 2 to 3 units for females and 3 to 4 units for males. 42 The antipsychotic dose was converted into chlorpromazine equivalents using published tables. 2,43,44 A medium positive correlation was found between antipsychotic dose and PSYRATS for hallucinations (r s = 0.33, df = 40, P < 0.05), sleep quality (r s = -0.40, df = 40, P < 0.05), and sleep efficiency (r s = -0.40, df = 40, P < 0.01). Analyses including these 3 variables controlled for chlorpromazine equivalent antipsychotic dose. No significant associations were found between antipsychotic dose and delusional severity, affective measures, working memory, and the time budget measure (all P > 0.05).
Hypothesis 1. Nightmares will be more prevalent in the context of psychosis than in the general population
This hypothesis was supported. Among the 40 participants with psychosis, 22 (55.0%, 95% CI 38.5% to 70.7%) experienced at least weekly nightmares (that is, 2 or more nightmares during a 2-week period). The confidence intervals from the current sample does not include the weekly prevalence rate (0.9 to 6.8) from large epidemiologic studies of the general population, [11] [12] [13] which implies that the difference is statistically significant (Figure 1 ).
Hypothesis 2. Nightmare frequency will be associated with poorer sleep (sleep quality and sleep efficiency)
This hypothesis was supported. A large positive correlation was found between nightmare frequency and overall (PSQI) sleep quality while controlling for antipsychotic dose (partial r s = 0.48, df = 37, P < 0.01). Nightmare frequency was also negatively correlated with sleep efficiency (hours asleep/hours spent in bed × 100) while controlling for antipsychotic dose (partial r s = -0.51, df = 37, P < 0.01). -related distress, rather  than the frequency with which they occur, will best  account for the association between nightmares and  daytime impairment (psychotic symptoms, affective  symptoms, and daytime activities) 
Hypothesis 3. Nightmare
while controlling for shared variance
This hypothesis was supported, as can be seen in Table  2 . Nightmare distress was significantly correlated with 4 measures of daytime psychological functioning: delusional severity, depression, anxiety, and stress. In contrast, there were trends indicating that nightmare frequency was correlated with 2 measures of psychological functioning: depression and daytime activity. However, these fell short of significance after controlling for multiple comparisons.
Hypothesis 4. Poorer sleep quality will be associated with poorer working memory. More specifically, it is expected that a higher frequency of nightmares will be associated with poorer working memory
This hypothesis was not supported. Overall sleep quality was not significantly correlated with working memory (partial r s = -0.06, df = 36, P = 0.70) while controlling for antipsychotic dose. Nightmare frequency was also not significantly correlated with working memory (r s = 0.02, df = 39, P = 0.90).
Exploratory analysis was undertaken to assess the link between nightmare distress and working memory. This revealed a large negative correlation between nightmare distress and working memory (r s = -0.50, df = 27, P < 0.01). This remained significant when controlling for variance in delusional severity (partial r s = -0.42, df = 24, P < 0.05) and depression (partial r s = -0.43, df = 24, P < 0.05), but not anxiety (partial r s = -0.36, df = 24, P = 0.07).
Discussion
This is the first study to investigate the occurrence of nightmares within a sample experiencing symptoms of psychosis and their relation with symptoms.
The key findings are that over one-half of the sample with psychosis (55%) reported experiencing weekly distressing nightmares, reflective of moderately severe pathology. 11 This is significantly higher than estimates of the prevalence rate (0.9% to 6.8%) from the general population. [11] [12] [13] People with psychosis experiencing frequent nightmares tended to have poorer sleep efficiency and sleep quality. However, it was higher levels of nightmare distress that was associated with more severe delusions, depression, anxiety, stress, and poorer working memory. Error bars for psychosis group indicate 95% confidence interval; error bars for general population indicate the range of values reported across all studies reviewed (0.9% to 6.8%).
The frequency of weekly nightmares in our sample was closely matched to other clinical groups, for example, PTSD (52% to 71%), 14, 15 and BPD (49%). 16 This is an important finding; nightmares are one of the most commonly reported symptoms of PTSD 45 and form part of the diagnostic criteria, yet our's is the first study to show that nightmares are also a common problem for people with psychosis.
The finding that nightmare distress better accounts for links with daytime psychiatric symptomatology than the prevalence of nightmares extends the results of a previous study from a nonclinical, student sample. 24 The finding that nightmare distress (rather than frequency) is key in determining psychological functioning also fits with investigations of the positive symptoms of psychosis. There is considerable evidence that members of the general population experience voices and unusual beliefs [46] [47] [48] ; however, it is the distress associated with these experiences that distinguishes whether a person has a need for care. [49] [50] [51] A PTSD screen revealed 42.5% of the current sample had probable PTSD, in line with high rates found in other samples with psychosis (14% to 78%). [52] [53] [54] However, nightmare distress was not correlated with PTSD symptoms in this sample with psychosis, and those who screened positive for PTSD did not experience more frequent nightmares or higher nightmare distress. Given that nightmares are considered a hallmark of PTSD, this was a surprising result. It is possible that nightmares are a common problem for people with psychosis in general, irrespective of PTSD symptoms.
Our study has several limitations. The sample was a convenience sample, which may result in a sample with lower levels of functional impairment, particularly in relation to the low levels of reported substance and alcohol use. Our study used a retrospective measurement of nightmares that has not been validated for people experiencing psychosis. The study could have benefited from a matched control group. For example, a clinical control group with affective symptoms alone would allow further investigation about whether nightmares are associated purely with psychotic symptoms, or rather whether they are better related to comorbid depression or anxiety. In addition, our study was a small, initial evaluation of a previously unexplored area. It was powered to detect a medium correlation between nightmares and daytime psychopathology, as found in a previous nonclinical sample. 24 A larger sample would allow for increased power to investigate the nonsignificant but promising associations between nightmare-related distress and both auditory hallucinations and activity levels, as well as controlling for the impact that individual medications (and their withdrawal) have on sleep and the emotional tone of dreams. 55 Future studies may try to elucidate the direction of causality between experiencing distressing nightmares and severity of delusions. Dreaming has been theorized to play a role in fear extinction and emotion regulation. 11, [56] [57] [58] These models would predict that nightmares result from disrupted processing of distressing daytime experiences via usual dreaming. However, an alternative model may suggest that sleep disturbance (and therefore nightmares) are key and result in the formation and maintenance of delusional ideas. 59 It is, of course, possible that the relation between nightmares and severity of daytime symptoms is bidirectional, as has been found in PTSD samples. 17 A more detailed analysis of the direction of causality and mechanism linking nightmares, delusional severity, and affective symptoms was beyond the scope of our study, but would be an interesting area for further investigation.
One method to investigate the causal relation between nightmares and delusional severity, affective symptoms, and working memory would be to investigate the impact of a nightmare-specific treatment such as Imagery Rehearsal Training, which has a good evidence base for treating posttraumatic nightmares, 45,60-65 and early evidence indicates that this is an acceptable treatment for people with psychotic symptoms. 66
Conclusion
Nightmares may be a common clinical characteristic for people experiencing psychotic symptoms. Further, the distress associated with them is associated with worse daytime symptoms. These results support the assertion of Krakow 18 that nightmares should be considered as a separate problem that can be comorbid with a range of other diagnoses, including BPD, 16 primary insomnia, 67 PTSD, 14, 15 and now psychosis.
